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Abstract 
The concept of reengineering and rewiring of pathways and gene regulatory networks for novel 
uses, and sometimes for mimicking natural systems for various uses in various disciplines 
gradually acquired the name “synthetic biology”. Synthetic biology, with foundations rooted in 
multiple disciplines like biological engineering, molecular biology, genetic engineering, and 
systems biology to name a few, is a new approach towards developing applications for solving 
current global problems in areas of food, agricultural, environmental, health (Weber et al., 
2008) and alternative energy. A synthetic biology approach was used to develop a positive 
feedback base gene regulatory circuit in E.coli. 
Positive feedback is a common mechanism used in the regulation of many gene circuits as it can 
amplify the response to inducers and also generate binary outputs and hysteresis. In the 
context of electrical circuit design, positive feedback is most often employed in the design of 
amplifiers. Similar approaches may therefore be applied to design modular amplifier for the 
design of synthetic gene circuits and cell-based sensors. 
A modular positive feedback circuit was developed that can function as a genetic signal 
amplifier, heightening the sensitivity to inducer signals as well as increasing maximum 
expression levels without the need for an external cofactor. The design utilizes a constitutively 
active, autoinducer-independent variant of the quorum-sensing regulator LuxR. The ability of 
the positive feedback module to separately amplify the output of a one-component tetracycline 
sensor and a two-component aspartate sensor was experimentally tested and validated. In 
each case, the positive feedback module amplified the response to the respective inducers, 
both with regards to the gain and sensitivity.  
The advantage of this design is that the actual feedback mechanism depends only on a single 
gene and does not require any other modulation. Furthermore, this circuit can amplify any 
transcriptional signal, not just one encoded within the circuit or as inducer concentration. As 
our design is modular, it can potentially be used as a component in the design of more complex 
synthetic gene circuits. 
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Chapter 1 Introduction and Literature Review 
1.1 Synthetic Biology 
Emerging disciplines like genomics, proteomics and metabolomics to name a few, have led to 
increased understanding of biology. The common underlying principle of these various 
disciplines is reductionism; i.e. the complex system is understood by reducing it down to its 
simpler constituents such as building blocks like proteins, DNA, RNA enzymes and their 
controlling mechanisms. The advances in recombinant biotechnology and computational 
biology continue to help in compiling the high-resolution ‘omics’ information in order to re-
create bio-molecular systems and to characterize their role in their native contexts.  
As we continue understanding the relationships between biological modules, we are also able 
to put them in novel contexts that are not seen in nature. Numerous endeavors have 
reengineered enzymes for the purpose of optimizing hard to produce drugs for industrial scale 
production (Stutzman-Engwall et al., 2005), introduced foreign enzymatic pathways into 
microbes to produce a desired product (Ro et al., 2006), and created novel gene regulation 
patterns to understand existing complex natural genetic circuits (Maeda and Sano, 2006b).This 
concept of reengineering and rewiring of pathways and gene regulatory networks for novel 
uses, and sometimes for mimicking natural systems for various uses in various disciplines has 
gradually acquired the name “synthetic biology”.  
Research in synthetic biology combines the “discovering” attitude of biology with the “building 
block-by-block” nature of engineering. Synthetic biology was formally described as “the design 
and construction of new biological parts, devices and systems and the redesign of existing 
natural biological systems for useful purposes” (Synthetic Biology, 2010). Synthetic biology, 
with foundations rooted in multiple disciplines like biological engineering, molecular biology, 
genetic engineering, and systems biology to name a few, is a new approach towards developing 
applications towards solving current global problems in areas of food, agricultural, 
environmental, health (Weber et al., 2008) and alternative energy (Lee et al., 2008).  
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1.1.1 Philosophy of Synthetic Biology 
Abstraction, standardization and synthesis are the three main components of the synthetic 
biology framework. Abstraction refers to a method of encapsulating the information contained 
in complex biological structures by means of simpler linguistic or graphical notation for the 
purpose of reducing the amount of information displayed in order to comprehend the system. 
Abstraction hierarchies are used in most engineering disciplines and in object oriented 
programming languages like C++. The ultimate goal is to be able to design synthetic systems 
with predictable behavior at a high level of abstraction using engineering tools, synthesize their 
DNA equivalents and deploy them in living cells. Abstractions commonly used in synthetic 
biology, such as ‘parts’, ‘devices’ and ‘systems’ as defined below represent specific genetic 
structures that encapsulate discrete functions (Synthetic Biology, 2010). 
Table 1. Abstraction hierarchy. 
Layer Description Example 
DNA  Sequence of nucleotides AGGAGG 
Part A sequence of nucleotides with a specific function Promoter 
Device Multiple parts with higher function A repressor  
System Multiple devices assembled together An oscillator 
 
The increase in use, design and construction of genetic circuits has led to standardization with 
respect to interfacing simpler biological parts (Voigt, 2006) like in any other discipline of 
engineering. The registry of standard biological parts, BioBricks, from MIT is a collection of 
standardized biological parts (Registry of Standard Biological Parts, 2010). 
The BioBricks Foundation’s registry currently consists thousands of genetic elements that 
encode for promoters, terminators, enzymes, reporters, ribosome binding sites, activators, 
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repressors and signaling and measurement systems. The availability of standardized interfaces 
(DNA motifs that permit recombinant assembly) allows rapid prototyping of genetic devices and 
troubleshooting (Shetty et al., 2008; Arkin, 2008). Individual parts with discrete functions can 
be tested and characterized to build higher order systems with more complexity using a limited 
subset of restriction enzymes and a fixed protocol. The parts or devices that do not function as 
per the design requirements can be identified and repaired or replaced easily (Rosenfeld et al., 
2005). Prof. Tom Knight of MIT proposed a BioBrick standard in 2003 that describes the 
composition of biological parts (Knight, 2003). Many students and synthetic biologists use this 
standard to make complex devices at “ The International Genetically Engineered Machines 
(IGEM) ” competition every year (IGEM, 2010). BioBricks were used to build biobrick vectors 
(Shetty et al., 2008). BioBricks have also been used for developing a variety of standardized 
parts for cyanobacteria (Huang et al., 2010), which is not as widely studied as E.coli. Alternative 
methods to standard molecular biology procedures like digestion and ligation were also 
developed to enable parallel assembly of higher order genetic devices (Sleight et al., 2010). 
1.1.2 Directions in Synthetic Biology 
Studies in synthetic biology over the last decade have taken three distinct directions and can be 
generically categorized as biomimetic chemistry, synthetic techniques and gene regulatory 
circuits.  
1.1.2.1 Biomimetic Chemistry 
Many studies attempted to recapitulate natural processes like protein translation outside the 
cell. Cell free systems use the catalytic machinery of the cells in order to achieve protein 
translation in-vitro by eliminating the cellular chassis (Jermutus et al., 1998; Jewett et al., 2008). 
Cell free technology is a potential protein production method for the biotechnological and 
pharmaceutical industry for the large-scale production of proteins and offers several 
advantages over in-vivo expression chasses like E.coli and Chinese Hamster Ovary (CHO) cells. 
The lack of a cell wall offers direct control over the cellular machinery and reaction conditions. 
Translation rates in natural cells are driven by the availability of the energy resource adenosine 
triphosphate (ATP). However, cell free systems are typically constrained by regeneration of ATP 
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through the use of expensive high-energy phosphate compounds, and they are also hindered by 
accumulation of inhibitory byproducts such as phosphate and changes in pH. In order to 
address this problem, Jewett and Swartz (Jewett and Swartz, 2004) developed a “cytomim” 
platform in which the cytoplasmic environment in E.coli was successfully mimicked with the use 
of pyruvate as the energy resource in order to achieve the cell free translation of a protein with 
higher translation efficiency. In a different study, in-vitro translation efficiency was also 
enhanced through the use of gold nano particle-DNA conjugates (Park and Hamad-Schifferli, 
2010).  
1.1.2.2 Synthetic Techniques 
Since the advent of recombinant DNA technology, the synthesis of huge DNA molecules has 
always been an objective. A special mention should be given to the scientists at the J Craig 
Venter Institute who achieved the synthesis of the entire 1.1 million base pair genome of 
Mycoplasma mycoides (Gibson et al., 2010). The genome was assembled inside a yeast cell and 
then later transplanted into a cell of a closely related species Mycoplasma capricolum (Lartigue 
et al., 2009). The ability to propagate synthetic genomes was demonstrated by replacing the 
genome of one bacterial strain with the genome of a different strain (Lartigue et al., 2007). 
After the cell had divided and new cells contained only proteins characteristic M.mycoides. 
These achievements demonstrate that synthetic biology is the new frontier of genetic 
engineering and gives unprecedented opportunities to battle global problems in food, health 
and fuels through the possibility of genome-scale reprogramming of cellular machinery. 
1.1.2.3 Gene Regulatory Circuits 
Most of the initial demonstrations of synthetic biology were simple gene regulatory circuits. 
The objectives of these studies were bottom up design of genetic parts and circuits in order to 
understand gene regulatory circuits. They laid the foundation for understanding complex 
biological systems in a new light. It is widely agreed that the first inaugural demonstrations of 
synthetic biology in its current definition were the genetic toggle switch built by Collins et al., 
(Gardner et al., 2000) and the repressilator by Elowitz et al., (Elowitz and Leibler, 2000). 
Transcriptional regulatory elements were used in both these circuits to demonstrate a flip-flop 
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memory module that switches between two states and a ring oscillator circuit respectively in 
E.coli. Green fluorescent protein was used as an alias for the transcriptional activity for both 
these studies. The design and characterization of these circuits showed that gene regulatory 
systems could be programmed and modeled just like their non-biological counterparts using 
deterministic and stochastic approaches and produce systems with a degree of predictability. 
These two papers garnered great interest in synthetic biology, leading to many similar studies 
and approaches. Among the three growth areas of synthetic biology, this work is most closely 
related to understanding synthetic gene regulatory circuits.  
1.2 Gene Regulatory Circuits 
The synthetic genetic toggle switch (Gardner et al., 2000) is an elegant recapitulation of the 
lysis-lysogeny decision events of E.coli infected with the bacteriophage . The bacteriophage  
consists of two promoters that are mutually repressed by the gene product of the other. The 
Cro protein represses the cI promoter and the CI repressor protein represses the cro promoter 
effectively switching the organism between the lysis and the lysogeny states of bacteriophage 
infection (Ptashne et al., 1982). Three different promoter-repressor pairs were used to 
construct different combinations of mutually repressing plasmids. The PL promoter from the 
bacteriophage  was used in conjunction with lacI repressor to repress the Ptrc2 promoter .The 
Ptrc2 promoter controlled the expression of the temperature sensitive cI-ts gene that translates 
into the  CI repressor protein which in turn represses the PL promoter. The third variant used 
the PLtetO-1 promoter in conjunction with Tet repressor. The system was manipulated using two 
different exogenous signals in order to activate gene production from each promoter and can 
be toggled between them. When one of the signals is removed the system retains or 
remembers its current state thus satisfying all the requirements of a toggle switch, flip-flop or a 
memory (Gardner et al., 2000). 
The ring oscillator circuit (Elowitz and Leibler, 2000) also called a repressilator. In this system, 
three promoter-repressor pairs are arranged in a cyclical fashion where each protein represses 
the transcription under the control of the next promoter. LacI protein represses the 
transcription of the tetR gene under the control of the tetracycline resistant transposon Tn10. 
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The tetR protein represses the transcription of the cI protein from bacteriophage , which in 
turn represses the lacI expression under the first promoter. The transcriptional activity was 
measured through green fluorescent protein expression on a separate reporter plasmid. The 
network resulted in oscillations that were slower than the cell division rate indicating that the 
cells carried the state of oscillation from one generation to the next. However, the cells were 
not synchronized and were studied in isolation (Elowitz and Leibler, 2000). 
1.2.1 Network Motifs 
Transcription regulation networks control the expression of genes. The transcription networks 
of well-studied model organisms like E.coli are made of a small set of recurring network motifs 
like feedback and feed forward loops. The same network motifs were found in different 
organisms ranging from simple bacteria (Eichenberger et al., 2004) and yeast to highly evolved 
eukaryotes like plants (Saddic et al., 2006) and humans (Boyer et al., 2005; Odom et al., 2004). 
Therefore, it was suggested that the network motifs are one of the foundational elements of 
complex regulatory networks (Alon, 2007; Milo et al., 2002). As more and more network motifs 
are discovered and characterized, abstractional hierarchy can be applied to the understanding 
of complex biological networks. Experimental testing of these network motifs will help us 
better identify their evolutionary significance and ultimately lead to better understanding of 
dynamic biological networks. 
1.2.2 Engineering Analogy 
The genetic switch and the oscillator paved the path for the application of engineering inspired 
design to biological systems and demonstrated the programmability of biological systems and 
different variations of the toggle (Atkinson et al., 2003) including some based on the RNA 
(Bayer and Smolke, 2005; Deans et al., 2007) and the timer circuit (Fung et al., 2005; Stricker et 
al., 2008) have since been developed ,validating the design based genetic circuit construction 
approach. Various genetic circuits that mimic electrical and electronic components have since 
been constructed and tested including pulse generators, boolean logic gates (Anderson et al., 
2007; Guet et al., 2002; Rackham and Chin, 2005), and filters (Sohka et al., 2009; Hooshangi et 
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al., 2005). A couple of examples of genetic circuits that mimic electrical and electronic 
components are described here. Basu and colleagues developed a gene network that acts like a 
pulse generator. It is a multi cellular system built in E.coli consisting of sender and receiver cells. 
The sender cells synthesize an inducer acyl homoserine lactone (AHL), which diffuses outside 
the cells to neighboring receiver cells. The pulse generator that responds to AHL is encoded in 
the receiver cells. A feed forward loop encoded in the pulse generator causes the cells to 
alternatively activate and repress the expression of green fluorescent protein (GFP) (Basu et al., 
2004). Sohka and colleagues (Sohka et al., 2009) constructed a band- pass filter for cellular ß 
lactamase activity in E.coli. ß lactamases catalyze the hydrolysis of pencillin antibiotics such as 
ampicillin that inhibit cell wall synthesis. The design was a combination of positive and negative 
selections for ß lactamase activity and analogous to an electronic band pass filter. Only those 
cells with ß lactamase activity above certain level were able to grow in the presence of 
ampicilin. 
1.2.3 Transcription Based Circuits 
The most common form of biosensing at the cellular level is achieved through the transcription 
mechanism. Promoters transcribe or repress a particular gene in response to its transcription 
factor. Many different promoters like lac, ara and tet and their response to their associated 
transcription factors are very well characterized. The ability of the promoter to respond to a 
signal molecule can be altered by introducing mutations to the promoter site. For instance, 
mammalian cells have been programmed to respond to antibiotics like Streptogramin 
(Fussenegger et al., 2000), Tetracycline (Gossen and Bujard, 1992) and macrolides (Weber et al., 
2002).  
1.2.4 Translation Based Circuits  
Translational and post-translational mechanisms can also be used in signal transduction. An 
RNA based gene regulation system was successfully demonstrated in mammalian cells where 
sequences of self-cleaving RNA aptamers were cloned into the sequences of genes. These 
ribozymes, when expressed, led to self-cleavage of the functional mRNA unit thus inhibiting the 
gene expression. Oligonucleotides that are complementary to the ribozyme sequences and 
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other small molecules inhibited self-cleavage of the mRNA (Yen et al., 2004). This technique can 
be used for the development of custom gene regulation systems that respond to any small 
molecule of interest and have huge potential in cell-based biosensors, the pharmaceutical 
industry and protein therapeutics.  
RNA molecules could potentially act as sensors for various environmental and chemical signals 
and were in biosensing applications as desribed below. RNA aptamers were linked and bound 
to RNA regulatory domains. The analyte molecule is recognized and bound by the aptamer 
resulting in a conformational change in the molecule. The conformational change causes the 
aptamer to break free from the RNA regulatory domain and inhibit or activate translation of the 
reporter protein (Bayer and Smolke, 2005). DsrA is an E.coli RNA regulatory region that 
interacts with two different RNA regulators H-NS and RpoS by decreasing and increasing them 
respectively (Lease and Belfort, 2000). DsRA therefore acts a single control switch with different 
regulatory outcomes.  
The approach to constructing synthetic biological systems has gradually moved from basic 
manipulation of intra-cellular transcriptional (Gardner et al., 2000) and translational (Bayer and 
Smolke, 2005) mechanisms to system level programming like intra-cellular communication 
(Basu et al., 2005; Basu et al., 2004). In both these publications, signal-processing architectures 
were built that can filter communication signals originating from 'sender' cells and can be 
programmed to form patterns. The circuits evolved from plasmid based transcriptional 
regulation systems into RNAi and translation-based systems (Rinaudo et al., 2007). Most of the 
circuits and genetic devices were designed for use in E.coli as the host organism or in other 
words “the chassis”. The test bed has gradually extended from easy-to-manipulate E.coli to 
more complex chasses like yeast and mammalian cells (Deans et al., 2007; Kramer and 
Fussenegger, 2005). Various comprehensive reviews on the progress of synthetic biology over 
the last decade are available (Bhalerao, 2009; Khalil and Collins, 2010; Gore and van 
Oudenaarden, 2009). Though synthetic biology is a nascent discipline, its approach has been 
used for various applications such as in biosensing, pharmaceuticals, therapeutics and fuels. 
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1.3 Real World Applications of Gene Regulatory Circuits 
The significant areas of contribution from synthetic biology as employed to gene regulatory 
circuits are metabolic engineering approaches - for manipulating existing pathways in 
organisms and introducing new pathways for the development of fuels and pharmaceutical 
products; and biosensing applications for a variety of analytes but mostly for use in diagnostics 
of diseases.   
1.3.1 Crossover of Synthetic Biology with Metabolic Engineering 
The common approaches towards making biofuel production more efficient are i) manipulating 
the pathways within the native organism and ii) introduction of these pathways into model 
organisms like E.coli and S.cerevisiae. Metabolic engineering approaches were applied to yeast 
for the production of ethanol from hemicellulose (Van Vleet and Jeffries, 2009) and also for the 
simultaneous fermentation of glucose and xylose (Jeffries, 2006). The engineered S. cerevisiae 
strain overexpressed Piromyces XylA xylose isomerase gene, and the native genes resposnsible 
for the conversion of xylulose to glycolytic intermediates. Pentose phosphate pathway was 
overexpressed by introducing fungal xylose isomerase thereby enabling xylose metabolism 
(Kuyper et al., 2005; Lee et al., 2008).  
1.3.2 Applications in Fuels 
Synthetic biology approaches are also making great strides in solving problems arising from 
increased energy demand. Biofuel alternatives to traditional fossil fuels are being explored. 
Certain microorganisms like S. cerevisiae have evolutionary advantage and are better suited for 
degrading cellulosic biomass into bioethanol. Hybrid processes that combine both biological 
and chemical production steps can lead to production of biofuels for use as alternative energy 
resources and would decrease the demand for fossil based fuels.  
Butanol offers many advantages like higher energy content and hydrophobicity as a substitute 
for gasoline when compared to ethanol. Typically Clostridium is used to produce butanol in 
mixed product fermentation. A synthetic pathway was engineered in E.coli to demonstrate the 
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possibility of producing 1-butanol in a non-native host (Atsumi et al., 2008a). The genes 
responsible for synthesis of isopropanol and butanol in Clostridium were expressed in E.coli 
(Hanai et al., 2007). S.cerevesiae was also used to produce higher alcohols and esters from 
amino acids. A metabolic engineering approach was used to produce six different higher chain 
alcohols including isobutanol, 1-butanol, 2-methyl-1-butanol, 3-methyl-1-butanol, and 2-
phenylethanol in E.coli from glucose (Atsumi et al., 2008b). Efforts are also being made to 
explore the fatty acid biosynthesis pathways of organisms like cyanobacteria and algae (Chisti, 
2007). 
1.3.3 Applications in Pharmaceuticals and Medicine 
Malaria affects three to five hundred million people annually (Marsh, 1998). The parasite 
Plasmodum falciparum is multi-drug resistant. Artemisinin, a sesquiterpene lactone 
endoperoxide extracted from Artemisia annua is very effective against multi-drug-resistant 
Plasmodium. It is in short supply however, and unaffordable to most malaria sufferers. The 
chemical synthesis of the end product artemisinin is difficult and expensive. However, the semi-
synthesis of artemisinin from its precursor artemisinic acid could be cost effective and reliable. 
Keasling et al. used a metabolic pathway reengineering approach to modify E.coli to produce 
higher levels of hard to produce drug artemisinic acid. They engineered E.coli to produce high 
titers of upto 100mg/L of artemisisnic acid using an engineered mevalonate pathway, 
amorphadiene synthase and cytochrome P450 monooxygenase from A.annua that performs a 
multi- step oxidation of amorpha-4, 11-diene to artemisinic acid (Newman et al., 2006b; Chang 
et al., 2007; Newman et al., 2006a) .  
1.3.4 Single Cell Biosensor (SCB) 
The cell can be considered as a signal-processing unit that is capable of distinguishing between 
different signals and integrating them in a biologically relevant manner and producing an 
output based on predefined logic (Bhalerao, 2009). ‘Single-cell biosensors’ (SCBs) are cells 
engineered to sense specific analytes and to produce a phenotypic response. This response can 
be interpreted as the presence or absence of the analyte or its concentration range. Because an 
SCB typically uses a biological or biochemical process to detect the analyte, the response can be 
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interpreted as a measure of the bioavailability of the analyte. This is an important class of 
application in synthetic biology, and one that is very closely related to this project. Therefore 
the topic of SCBs has been considered in detail in its own section below.  
1.4 Design of a Single Cell Biosensor (SCB) 
A biosensor is usually made up of a detection layer followed by the transduction of the 
detection signal to the display or the reporting layer. Internal sensors of a control system that 
are not for human interaction, like the error in a cruise control usually are missing the display 
layer. In a transcriptional biosensor, the detection mechanism can be compared to the 
activation of the promoter by the analyte, the transduction mechanism to the transcription of 
the mRNA, and the reporter mechanism to the translation of the reporter gene into a protein 
(Figure 1). 
Figure 1. Layers of a biosensor and relevance to transcriptional gene circuit. 
Biosensors can be abstracted to have three layers, a sensory detection layer, signal 
transduction and the reporting layer. In a transcriptional biosensor, the detection mechanism 
can be compared to the activation of the promoter by the analyte, the transduction mechanism 
to the transcription of the mRNA, and the reporter mechanism to the translation of the 
reporter gene into a protein. 
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1.4.1 Examples of Single Cell Biosensors 
Synthetic biology approaches have also been used for constructing cells capable of sensing their 
environment. Such systems have applications in drug discovery and protein based therapeutics 
for diseases. E.coli was engineered to respond to their environment and selectively invade 
cancer cells without affecting healthy cells (Anderson et al., 2006). The inv gene that encodes 
invasin from Yersinia pseudotuberculosis was expressed in E.coli. Invasin binds to surface of ß1-
integrins on mammalian cell surfaces and induces cellular uptake and was used to invade 
mammalian cells through adhesion. E.coli was designed to invade the mammalian cells at high 
cell density after anaerobic growth through the use of the quorum sensing mechanism of the 
lux operon and through induction of the arabinose operon. A synthetic platform was developed 
for the purposes of screening of small molecules that could increase the effectiveness of 
ethionamide (Weber et al., 2008). Ethionamide is a mycobacterium tuberculosis antibiotic used 
in the treatment of “superbugs” like multidrug resistant tuberculosis. The repressor protein 
ethR represses the transcription of enzyme ethA rendering ethionamide-based treatment 
ineffective. An ethR-based transactivator of a reporter gene was used to screen cells with ethR 
repressors and effectively repeal them thus making the drug more effective. Such an approach 
could be effectively applied to other disease causing drug resistant superbugs. 
Genetic circuits were built to monitor the redox balance as an indicator for nutrient and oxygen 
availability (Weber et al., 2006) and other novel metabolites like nicotine (Malphettes et al., 
2005). Genetic circuits in which genes could be regulated by addition of acetaldehyde in the 
gaseous form (Weber et al., 2004) and light sensitive E.coli (Levskaya et al., 2005) were 
developed and tested. These approaches can be seen in both bacterial based systems and 
mammalian systems where transcription factors are fused to a transactivation domain in order 
to regulate the gene expression through inducer dosage. The ability to create custom sensory 
domains that respond to a signal of interest could have far reaching implications in transgene 
therapy and biopharmaceuticals and synthetic biology allows us to do so. 
1.4.2 Two-component Cell Signaling Systems and Framework 
In the context of this study, the cell is considered as a signal-processing unit (Bhalerao, 2009). 
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Typically, the sensory elements used in SCBs are two-component signal transduction systems. 
They are composed of an outer signal receptor that is exposed to the environment and 
responds to changes in the native environment of the cell like chemical concentration, 
osmolarity and light intensity, to name a few. The receptor is linked to an inner cytoplasmic 
kinase through a transmembrane protein. A variety of hybrid receptors were developed using 
two component signal transduction systems, where the signal receptor of one system is fused 
to the transmembrane and the cytoplasmic unit of a different system, including light (Levskaya 
et al., 2005), various amino acids (Jin and Inouye, 1993; Michalodimitrakis et al., 2005) and 
sugars (Dueber et al., 2003; Dattelbaum et al., 2005).  
Taz is a chimeric transmembrane receptor comprising of the periplasmic region of Tar, an 
aspartate receptor and the cytoplasmic domain of EnvZ, an osmosensor (Jin and Inouye, 1993). 
In the presence of aspartate, Taz can modulate the kinase to phosphatase ratio of OmpR. The 
phosphorylated OmpR-P binds to the OmpC promoter and switches on any genes under its 
control (Figure 2). 
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Figure 2. Two-component signaling systems with hybrid receptors. 
Two-component-signaling systems are composed of an outer signal receptor that responds to 
changes in the native environment of the cell. Hybrid receptors have the signal receptor of one 
system fused to the transmembrane and the cytoplasmic unit of a different system. Taz is a 
chimeric transmembrane receptor containing periplasmic region of aspartate receptor Tar and 
the cytoplasmic domain of osmosensor EnvZ. In the presence of aspartate, Taz modulates the 
kinase to phosphatase ratio of OmpR. The phosphorylated OmpR-P binds to the OmpC 
promoter and switches on any genes under its control.                                
1.5 Amplification in Biosensors 
 “Biosensor” is a term broadly used to refer to sensor systems that are designed to detect or 
quantify the presence of a biological analyte. Furthermore in a biosensor, the recognition 
element of the sensor, which discriminates between the analyte from its environment, 
frequently exploits biochemical specificity. In addition to biochemical recognition, a biosensor 
system typically consists of transduction and reporting elements. Frequently, signal-processing 
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elements such as filters and amplifiers are also included in the biosensing system.  
Whole organism biosensors are a special case of biosensors where all the elements of the 
sensor are integrated into one organism, which can be uni- or multi-cellular. Multi-cellular 
biosensors like the daphnia used for toxicity testing of water bodies are non-quantifiable and 
typically take a long time (a few days to attain a mature stage) thereby resulting in low 
sensitivity (Leung and Bulkley, 1979). SCBs, based on easily available platforms like various 
strains of E.coli or S.cerevisiae, are also inexpensive to culture, have a rapid generation rate and 
the reporting mechanism is faster relative to a multi-cellular system.  
Computational approaches were also used to design receptors to specific analytes (Fazelinia et 
al., 2007; Tang et al., 2008). Computational approaches to designing signal receptors not only 
increase the range of analytes for which biosensors can be developed but also provide 
exogeneous sensing capabilities where the analyte does not enter the cell. A variety of signal 
receptors were found in probiotic lactobacilli (Wall et al., 2003) and were used as biosensors to 
investigate the binding to specific A-antigen expressed in the intestinal mucosa (Uchida et al., 
2006).  
1.5.1 Rationale 
In signal receptor based biosensors, the possibility of non-detection or the dependence of 
threshold parameters to identify between true positives and false positives is rather high. In 
some cases, the signal maybe too generic or weak to characterize in a complex environment. A 
good example is the logical AND gate developed by Anderson (Anderson et al., 2007) that could 
be used to integrate multiple signals into one genetic circuit thereby rendering specificity to the 
signal. Genetic biosensors like this could be useful for communicating the state of a specific 
microenvironment within a mixture of environmental conditions, such as temperature, 
metabolite levels or cell density. Such biosensors could be envisioned to be of great use in 
bioprocessing industry for use within bioreactors.  
One more approach to render specificity to a weak signal could be amplification. The presence 
of an amplification mechanism can be envisioned to decouple the performance of the 
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biosensor from sensitivity, analyte-signal receptor binding dynamics and threshold value 
dependence, enabling us to distinguish between true and false positives.  
1.5.2 Objectives of the Study 
The objective of this work was to construct and demonstrate a signal amplifier in the context of 
an SCB using the synthetic biology approach of abstraction, synthesis and and modularity.  A 
positive feedback motif was chosen in order to leverage the associated properties like 
amplification and hypersensitivity. The survey of positive feedback motifs in literature and their 
applications for uses in synthetic biology follows this section.  The positive feedback based gene 
amplifier was designed to encompass all the prominent features of a positive feedback system 
including:  
1) Amplification: The final level of output using the PF gene amplifier should be significantly 
higher than the control.  
2) Increased sensitivity: The PF gene amplifier system should respond to inducer signals of 
weaker strength than the control with no positive feedback. 
3) Bistability: The PF gene amplifier system was able to exist at two different steady states  
4) Modularity: The PF gene amplifier should be modular and easily switchable and applicable in 
different scenarios.  
1.5.3 Feedback Regulation 
Cellular processes in living organisms are governed by interactions between various types of 
molecules such as proteins, DNA, RNA and enzymes. The interactions between proteins, their 
transcription factors (TF) and their target genes play a major role in the expression or 
suppression of a gene. These interactions can be studied and described as regulatory gene 
transcriptional networks and are ubiquitous in most of the biological processes. These networks 
are largely composed of a recurring set of network motifs found in bacteria, yeast, plants and 
animals. 
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Feedback is a very common network motif found in prokaryotic and eukaryotic organisms. In 
some cases, feedback is implemented via transcriptional control, i.e. through the action of gene 
products as transcription factors. When the transcriptional factor directly affects its own 
transcription, either in a positive or negative manner, it is said to assume an “autoregulatory” 
role. When an autoregulatory transcription factor enhances its own production, the circuit is 
said to involve positive feedback and the autoregulatory transcription factor is called an auto-
inducer. Likewise, when the gene product suppresses its own production, the circuit is said to 
involve negative feedback and the autoregulatory transcription factor is called an auto-
repressor. Autoregulatory behavior is analogous to feedback loops in electromechanical control 
systems.  
1.5.4 Positive Feedback Systems 
Positive feedback (PF) is a commonly seen mechanism in genetic circuits (Mitrophanov and 
Groisman, 2008). In the lac operon, LacI normally acts a repressor and represses the 
transcription of the lacZYA operon. However in the presence of allolactose inducer, it cannot 
bind to the lac operator anymore and is derepressed, leading to the production of LacY protein 
.The LacY protein is responsible for the intake of lactose and its subsequent conversion to 
allolactose leading to the production of more LacY protein. Thus, there is a Positive Feedback 
Loop (PFL) involving allolactose and LacY. However there is also an inbuilt negative feedback 
loop in the form of LacZ that metabolizes allolactose. Therefore, the amount of allolactose 
available for the derepression of LacI is decreased, ultimately leading to repression of the 
lacZYA operon (Lewis, 2005; Jacob and Monod, 1961).  
The mutual repression network seen in the phage lambda lysis-lysogeny decision-making circuit 
is also an example of a positive feedback loop. The CI protein is an activator for its production 
but also acts as a repressor at very high levels of CI. The CI protein also acts as repressor for the 
cro and the CI genes resulting in a negative feedback loop (NFL) embedded in a PFL (Ptashne et 
al., 1982; Tian and Burrage, 2004; Dodd et al., 2005). In a number of synthetic biology 
applications, positive feedback has been used to design switches, oscillators, and amplifiers. 
Besckei and coworkers (Becskei et al., 2001), for example, showed in yeast that a simple 
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positive feedback loop could transform a graded response to an inducer into a binary one. 
Likewise, Kramer and Fussenegger (Kramer and Fussenegger, 2005) showed that positive 
feedback could be used to generate hysteresis with respect to an inducer in mammalian cells. 
Maeda and Sano (Maeda and Sano, 2006b) analyzed a synthetic positive feedback loop in E.coli 
and demonstrated that it could give rise to either a graded or hysteretic response depending on 
the specific configuration. In terms of building circuits, Ajo-Franklin and coworkers 
demonstrated that positive feedback could be used to engineer memory into yeast cells (Ajo-
Franklin et al., 2007). Stricker and coworkers, on the other hand, built a simple oscillator by 
coupling positive feedback with negative feedback (Stricker et al., 2008). In work most closely 
related to the present study, Sayut and coworkers demonstrated that a positive feedback loop 
could make the transcriptional activity of the quorum-sensing regulator LuxR more sensitive to 
autoinducer (Sayut et al., 2006). In these regards, their design is most closely related to how 
positive feedback is typically employed in electronic circuits, namely to amplify the response to 
a signal. 
1.5.5 LuxR-Based Implementation of the Positive Feedback 
Acylhomoserine lactone-mediated quorum sensing and response is very commonly found in 
Gram-negative bacteria. A typical example of this kind is cell density dependent gene regulation 
and the activation of the Vibrio ﬁscheri luminescence (lux) operon by LuxR. LuxR function 
requires sufficient concentrations of the diffusible signal, N- (3-oxohexanoyl)-homoserine 
lactone (3-oxo-C6-HSL) also called AHL (acyl HSL), which is a product of LuxI. A fragment of V. 
fischeri DNA that encodes all of the functions necessary for autoinducible luminescence was 
cloned into E.coli (Engebrecht et al., 1983). There are seven different lux genes that are 
required for luminescence in E.coli. They are organized as two divergently transcribed units. 
One unit contains the LuxR gene that encodes the LuxR protein and is required for a response 
to auto inducer. The other unit is activated by the LuxR protein in the presence of autoinducer 
and contains luxA and luxB that encode for the  and  subunits of luciferase, luxC, luxD, and 
luxE that encode for polypeptides involved in synthesis of the aldehyde substrate for luciferase 
and finally luxI that is required for synthesis of autoinducer by E.coli (Figure 4). 
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1.5.6 Transcriptional Regulators Responsive to AHL 
The LuxR family of proteins usually are about 250 amino acids in length and are composed of 
two functional domains: N-terminal domain that is involved in AHL-binding and a C-terminal 
transcription regulation domain, which includes a helix-turn-helix (HTH) DNA-binding motif. The 
LuxR-type proteins interact with DNA in a dimeric state and specifically recognize a symmetric 
sequence located in the regulatory regions of the target genes. Most of them are activators and 
the regulatory protein/DNA interaction causes the recruitment of the RNA polymerase to the 
promoter and, therefore, the transcription of the target genes. The LuxR protein is predicted to 
be 250 amino acid residues. Randomly generated point mutation studies indicate that two 
regions of the LuxR protein are critical for activity. Residues 79-127 are involved in autoinducer 
binding, and residues 184-230 constitute the highly conserved helix-turn-helix region of the 
LuxR family is involved in lux DNA binding (Slock et al., 1990). 
1.5.6.1 Lux Regulatory Region (Consensus Binding Sequence) 
The lux box (Figure 3) is a 20-bp inverted repeat centered at -42.5 bp from the start of luxI 
transcription and is a binding site for LuxR. Lux box-type sequences have also been identified in 
the binding sites of other LuxR members like TraR and LasR. 
 
Figure 3. Lux box. 
Lux box is a binding site for LuxR and is a 20-bp inverted repeat centered at -42.5 bp from the 
start of luxI transcription start codon. 
1.5.6.2 AHL Binding Leads to Multimerisation 
AHL binding causes large conformational changes and change in transcriptional activity of the 
regulators. For most of the activators of the LuxR family, AHL binding induces dimerization of 
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the protein, which is a prerequisite for the activation of transcription. TraR, LuxR, RhlR and LasR 
bind to their target DNA only after dimerization and in the presence of their cognate 
autoinducer. 
1.5.7 Autoinducer Independence 
Mutations within the LuxR can make it autoinducer independent. It is of significance in this 
study in order to make LuxR activation independent of the cell density and the auotinducer 
AHL. 
1.5.7.1 Point Mutation 
Point mutations have been identified that result in the activation of LuxR in the absence of the 
autoinducer. The residue Ala221 to Val 221 substitution renders LuxR capable of activating the 
expression of target genes independent of the presence of AHL. Since the resulting mutant 
Ala221 -> Val was not affected in the autoinducer binding, this residue enables the N-terminal 
domain to inhibit the activity of the C-terminal domain (Poellinger et al., 1995). 
1.5.7.2 Deletion of N Terminal Domain 
Deletion of the LuxR N-terminal domain results in a derivative that is able to interact with DNA 
and able to activate the transcription of target genes, in the absence of AHL.  
LuxRN 
LuxRN, a 95-residue C-terminal fragment of LuxR, binds DNA and activates transcription of the 
lux operon in a signal- independent manner (Choi and Greenberg, 1991). LuxRN purifies as a 
monomer and the region required for oligomerization resides in the N-terminal domain of the 
full-length polypeptide. Only a small part of this oligomerization region exists on LuxRN 
(Stevens et al., 1994). The N-terminal domain masks the C-terminal DNA binding domain in the 
absence of AHL and thus interferes with DNA binding. One dimer activation model states that 
binding of the appropriate ligand to the activator induced conformational changes, which led to 
the exposure of the DNA binding site. 
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LuxRN Binding Affinity to Lux Promoter 
Neither LuxRN nor RNAP alone bind tightly to the luxI promoter region, but together they 
protect a region extending from -54.5 to +6 against DNase I digestion in vitro (Stevens et al., 
1994). Because LuxRN by itself does not protect the lux box from DNase I digestion, it can be 
assumed that LuxRN binds to the lux box and RNAP to the downstream region in the DNaseI 
protection experiments. Because LuxRN is monomeric, it is possible that activation of the luxI 
promoter by this protein should only require a lux box half-site to be occupied if a contact with 
RNAP adjacent to that half- site is necessary for LuxR activity. 
1.5.8 Structure of TraR 
The crystal structure of TraR, a luxR type protein has been determined (Qin et al., 2000). TraR is 
a dimer in solution and binds target promoters in vitro as a dimer. TraR was crystallized in the 
presence of OOHL and a self- complementary oligonucleotide containing the tra box sequence. 
The crystal asymmetric unit contains two structurally similar TraR dimers, each binding two 
molecules of OOHL and one duplex DNA fragment. The N-terminal domain of each monomer 
(residues 1–162) binds one molecule of OOHL .The C- terminal domain (residues 175–234) 
binds to half of a tra box. A twelve-residue amino acid linker joins these domains The N-
terminal and C-terminal domains both contribute to protein dimerization. The two N-terminal 
domains dimerize chiefly through -helix 9 of each protomer (the longest -helix in the 
protein), forming a coiled-coil, whereas -helix 1 of each subunit contacts -helix 8 of the 
opposite subunit. The two C-terminal domains dimerize through -helix 13 of each subunit, 
which form a second coiled-coil. Additional contacts are made by salt bridges between the C-
terminal carboxylate of each subunit and Arg 230 of the opposite subunit (Zhang et al., 2002). 
Analysis of heterodimers formed between TraR and its deletion mutants localized the 
dimerization domain to a region between residues 49 and 156. The binding signal drives 
dimerization of TraR and its release from membranes into the cytoplasm. 
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Figure 4. LuxICDABE operon and mutations for autoinducer independence. 
a. luxR gene encodes the LuxR protein and is required for a response to AHL. luxA and luxB 
encode for the  and  subunits of luciferase. luxC, luxD, and lxuE encode for polypeptides 
involved in synthesis of luciferase aldehyde substrate. luxI is required for synthesis of 
autoinducer by E.coli. The lux promoter is activated by LuxR protein in the presence of 
autoinducer. b. Residues 79-127 are involved in autoinducer binding, and residues 184-230 
constitute the lux DNA binding domain c. Ala221 to Val substitution disables the N-terminal 
domain to inhibit the activity of the C-terminal domain and makes LuxR capable of activating 
the expression of target genes independent of the presence of AHL. d. LuxRN, a 95-residue C-
terminal fragment of LuxR, binds DNA and activates transcription of the lux operon in a signal- 
independent manner. 
1.5.9 Testbed 
Positive feedback can result in amplification behavior. LuxR can be modified to make it 
autoinducer independent and also act as an autoregulator. Therefore, luxR was chosen as the 
feedback component of the positive feedback based amplifier. The simplest realization of this 
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system was a one-component sensor in E.coli. The SCB responds to signal of interest. The 
positive feedback signal amplifier amplifies this response .The response was measured through 
a fluorescent protein. The anhydro tetracycline sensor was chosen because of ease of use and 
availability. 
Once the system was developed and characterized, it was then tested for modularity. The 
feedback amplifier was not altered. The system was manipulated only at the sensor level and 
developed for use as an SCB for an analyte of interest. The two-component Tar-EnvZ fusion Taz 
was chosen for use as an aspartate biosensor. The details of design, development and 
characterization are presented in the next chapter. 
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Chapter 2 Materials and Methods 
2.1 Media and Growth Conditions 
All cultures and experiments involving the one component tetracycline sensor were performed 
in Luria-Bertani (LB) broth. The LB broth composition is given in Table 2. 
Table 2. LB broth. 
Tryptone 10 g 
Yeast extract  5   g 
NaCl  10 g 
 
1000 ml of water was then added and the solution was autoclaved . 
All the cultures and experiments involving the two-component aspartate sensor were 
performed in M9 minimal media. 10x M9 salts stock solution was prepared as shown in Table 3. 
Table 3. 10X M9 stock solution. 
Na2HPO4 x 7H2O  60 g 
KH2PO4  30 g 
NaCl    5 g 
NH4Cl    10 g 
 
1000 ml of water was then added and the solution was autoclaved.  
The 1x M9 minimal media was then made using the stock solution as shown in Table 4. 
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Table 4. 1X M9 minimal media. 
Sterile water  900 ml 
M9 salts 10X stock solution 100 ml 
Autoclaved 1 M MgSO4  
1     ml 
Autoclaved 1 M CaCl2 
0.1 ml 
 
Supplements were added to the M9 minimal media as shown in Table 5. 
Table 5. Supplements to M9 minimal media. 
Glucose 0.4% 
Thiamine 1 μg/mL 
Biotin  1 μg/mL 
 
All the experiments were performed at 37˚C unless noted otherwise. Antibiotics were used at 
concentrations as shown in Table 6. 
Table 6. Antibiotics. 
Ampicillin 100 µg/mL 
Chloramphenicol 34   µg/mL 
Kanamycin 40   µg/mL. 
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Primers were purchased from IDT Inc. (Coralville, IA). Restriction enzymes were purchased from 
New England Biolabs Inc. (Ipswitch, MA) and Fermentas Inc. (Glen Burnie, MD) and used 
according to the manufacturer’s recommendations.  
2.2 Bacterial Strains and Cell Line Construction 
All the cloning steps were performed in E.coli strain DH5α (F- endA1 glnV44 thi-1 recA1 relA1 
gyrA96 deoR nupG Φ80dlacZΔM15 Δ (lacZYA-argF) U169, hsdR17 (rK
- mK
+), λ–). The experiments 
involving aspartate induction were performed in GN101 (F- ilvG rfb-50 rph-1 ΔenvZ::FRT). Strain 
GN101 was constructed first by P1vir transduction of the ΔenvZ::kan insert from JW3367-3 (The 
E.coli Genetic Stock Center, CGSC# 10509) into strain MG1655.The process of lysate 
preparation and the transduction are described below. 
2.2.1 Preparation of the P1 Phage Lysate From the Donor Strain JW3367-3 
1. An over night culture of the donor strain ΔenvZ :: kan insert from JW3367-3 was made 
(The E.coli Genetic Stock Center, CGSC# 10509) 
2. The donor strain over night culture was diluted to a ratio of 1:50 into fresh LB medium + 
5mM CaCl2 + 0.2% glucose  
3. The subculture was then grown at 37˚C for a period of 1 -2 hours until visible growth 
4. Few drops of P1 phage lysate were dropped into the subculture and grown further for 3 
hours until the culture lysed 
5. Chloroform was then added to the lysate and mixed thoroughly. 
6. The cellular debris was centrifuged away and the lysate stored at 4˚C for further use. 
2.2.2 Transduction 
1. 4 ml of the recipient strain MG1655 was grown overnight in LB medium  
2. The over night culture was centrifuged at a speed of 3000 rpm for 5 minutes and 
resuspended in an equal volume of fresh LB medium + 5mM CaCl2 + 100 mM MgSO4) 
3. Few drops of the donor P1 lysate prepared above and 200 µL of the cells prepared in 
step 2 were incubated at 37˚C for 30-45 minutes. The donor lysate with LB Medium and 
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recipient cells with LB medium were similarly treated for control experiments. 
4. 200 µL of 100 mM Na-Citrate and 1 ml of LB medium was then added and further grown 
for 1.5 to 2 hours. 
5. The cells were centrifuged at 3000 rpm for 5 minutes and resuspended in 200 µL of LB+ 
100mM Na-Citrate and spread on selective plates and incubated at 37˚C 
The colonies obtained the following day were streaked for 2 times consecutively on plates 
containing the selective antibiotic and sodium citrate to avoid phage contamination. 
The kanamycin antibiotic cassette from the FRT-Kan-FRT insert was then removed by 
transformation of pCP20 into the strain and selection on ampicillin at 30˚C (Datsenko and 
Wanner, 2000). Loss of the helper plasmid pCP20 was obtained by growth at 42˚C under non-
selective conditions on LB agar.  
All subsequent experiments involving anhydrotetracycline (aTc) induction were conducted in 
E.coli strain GN100 (F- ilvG rfb-50 rph-1 ΔenvZ::FRT attBλ::[PN25-tetR lacI
q spcR]). Lastly, the 
chromosomally integrated TetR/LacI expression cassette from DH5αZ1 (Lutz and Bujard, 1997) 
was moved into GN101 strain by P1vir transduction described as above, yielding strain GN100. 
2.3 Plasmid Construction 
All the plasmids used are provided in Tables 7 and 8 and the primers are provided in Table 9. 
The following constraints have been taking into account for the construction of the plasmids. 
1. The two and three plasmid systems should have compatible origins of replication.  
2. The antibiotic resistance markers should be different to enable selection for cells 
transformed with multiple plasmids.  
The aTC sensor plasmids pGN3 and pGN12 were designed to have colE1 origin of replication 
and kanamycin selection marker. The positive feedback plasmids and the non- positive 
feedback plasmids with the Green Fluorescent Protein (GFP) reporter were designed with p15A 
origin of replication and chloramphenicol selection marker. The aspartate sensor plasmid was 
designed with pSC101 origin that was compatible with both colE1 and p15A origins of 
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replication and has the ampicillin selection marker. 
The plasmid pPROTetE-Kan-p15A was made by swapping the ColE1 origin of pPROTet.E with the 
p15A origin from pZA34-luc (Lutz and Bujard, 1997) using the restriction sites XbaI and SacI and 
by swapping the chloramphenicol resistance gene with the kanamycin resistance gene from 
pZE21 using the restriction sites XhoI and SacI. The plasmid pPROTetE-Amp was made by 
replacing the chloramphenicol resistance gene in pPROTet.E with the ampicillin resistance gene 
from pZE12(Lutz and Bujard, 1997) using the restriction sites XhoI and SacI. 
2.3.1 Construction of the Non-Positive Feedback Plasmid 
The luxI-GFP transcriptional fusion was made first by PCR amplification of the luxI promoter 
using the plasmid pluxGFPuv (You et al., 2004) as the template with the primers KW134F. The 
resulting fragment was then cloned into the plasmid pPROTet. E using the restriction sites EcoRI 
and AatII, yielding the plasmid pGN23. The green fluorescent protein (GFP) was PCR amplified 
from pPROBE-gfp [tagless] (Miller et al., 2000) using primers GN10F and GN10R. The resulting 
fragment was then cloned into the EcoRI and BamHI restriction sites of the pGN23, yielding the 
plasmid pGN69 (Figure 6).  
2.3.2 Construction of the aTc Sensor Plasmids 
The LuxR* (LuxR [A221V]) expression plasmids were constructed using two rounds of PCR. In 
the first round, the luxR gene was amplified with primers KW78F1 and KW078R using pLuxRI 
(You et al., 2004) as the template. The resulting product was then used as a template for a 
second round of PCR this time using primers KW078F2 and KW078R. It was then digested with 
EcoRI and SalI and sub-cloned into the EcoRI and SalI restriction sites of pPROTetE-Kan-p15A. 
Enzymatic inverse PCR was used to introduce the Ala221Val (GCG->GTG) point mutation in the 
luxR gene with primers KW079F. The resulting PCR product was then digested with BsaI and 
ligated to obtain pGN3.  
The luxRΔ2-156 expression plasmid was also constructed using two rounds of PCR. The luxR gene 
was first amplified with primers KW112F and KW078R using pLuxRI2 as the template. The 
resulting PCR product was then amplified using primers KW078F2 and KW078R. It was then 
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cloned into the EcoRI and SalI cut-sites of pPROTetE-Kan-p15A, yielding pGN11. Similarly, 
luxRΔ2-162 was made by amplifying the luxR gene with primers KW113F and KW078R using 
pLuxRI2 as the template. The resulting product was amplified again as before using primers 
KW078F2 and KW078R. The PCR product was then digested with EcoRI and SalI and sub-cloned 
into the EcoRI and SalI cut-sites of pPROTetE-Kan-p15A, yielding the luxRΔ2-162 expression 
plasmid pGN12 (Figure 7). 
2.3.3 Construction of the Positive Feedback Plasmids 
The positive-feedback module was constructed using two rounds of PCR. In the first round, the 
primers GN09F2 and KW171R were used to amplify the luxRΔ2-162 domain using pLuxRI2 [12] as 
the template. The resulting PCR product was then used as template for a second round of PCR 
this time using primers GN09F and KW171R. The resulting fragment was then digested with 
BamHI and NotI and sub-cloned into pGN69, yielding pGN68 (Figure 5). Similarly, pGN29 
consists of a plasmid harboring the ColE1 origin of replication, chloramphenicol resistance 
(Cmr), a green fluorescent protein (gfp) and a copy of luxR* under the control of the luxI 
promoter PluxI. 
The aspartate positive feedback module was constructed first by amplifying the PompC promoter 
(genomic region 2310762-2310962) using primers GN03F and GN05R. The PCR product was 
then digested with XhoI and EcoRI and sub-cloned into the respective sites of pPROTetE-Kan-
p15A, thus replacing the native PLtetO-1 promoter with the PompC promoter. The primers GN06F2 
and KW171R were used to amplify luxRΔ2-162 using pGN68 as the template. The resulting PCR 
product was digested with SalI and NotI and then sub-cloned into the respective sites of 
pPROTetE-Kan-p15A, yielding pGN62. 
2.3.4 Construction of the Aspartate Sensor Plasmid 
The aspartate sensor module was constructed first amplifying the taz gene from pTJ003 (Jin and 
Inouye, 1993) using the primers GN13F and GN12R. The PCR product was then digested with 
EcoRI and SacI and cloned into the unique respective restriction sites, yielding pGN76. The 
ColE1 origin in pGN76 was then replaced with the pSC101 origin from the pZS24 plasmid using 
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the restriction sites AvrII and SacI, yielding pGN77.  
 
Figure 5. Positive feedback plasmid pGN68. 
The positive feedback plasmid pGN68 containing the Plux promoter, the GFP gene, luxR(2-168), 
ColE1 origin of replication and the chloramphenicol marker.pGN29 is similar and has 
luxR*(Ala221-Val) instead of luxR(2-168). All the plasmid diagrams (Figures 5, 6 and 7) have 
been made using PlasMapper(Dong et al., 2004). 
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Figure 6. Non-positive feedback plasmid pGN69. 
The non-positive feedback plasmid pGN69 has the PluxI promoter, GFP, ColE1 origin of 
replication and the chloramphenicol selection marker. 
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Figure 7. aTc sensor plasmid pGN12. 
The aTc sensor plasmid pGN12 has the PlTetO-1 promoter, the luxR(2-162), p15A origin of 
replication and the Kanamycin marker.  
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2.4 Fluorescence Assays 
To measure fluorescent protein expression, cultures were first grown overnight and then 
subcultured to an OD600 of 0.05 in fresh media. The cultures were first allowed to grow to an 
OD600 of 0.20, at which point the inducer was added. The cultures were then grown overnight 
prior to taking the measurements. 100 µL of the culture was then transferred into a 96 well 
microplate, and the relative fluorescence and optical density at 600 nm (OD600) were measured 
using a Tecan Safire2 microplate reader. The fluorescence readings, given as relative 
fluorescence units (RFU), were normalized with the OD600 absorbance to account for cell 
density. All experiments were performed in triplicate with 95% confidence intervals reported. 
2.5 Experiments for Measurement of Kinetics 
Cultures were grown overnight at 37°C with vigorous shaking. The next morning, they were 
subcultured to an OD of 0.05 in fresh medium in triplicates and allowed to grow to an OD of 
0.15. They were then induced with various levels of aTc ranging from 0 to 100ng/ml. Every 
hour, 100 µl of the cultures at different levels of induction conditions were transferred to  a 96-
well microplate. The temperature was maintained at 37°C, and fluorescence and OD readings 
were taken. All experiments were done in triplicate and average values with the 95% confidence 
intervals reported. 
2.6 Single Cell Measurements 
The cells were first grown overnight at 37°C in non-inducing conditions coupled with vigorous 
shaking. The overnight cultures were then sub-cultured to a ratio of 1:200 in fresh LB medium 
and grown to an OD of 0.05 at 37°C. Once an OD of 0.05 was attained, they were then induced 
with various concentrations of the inducer. 200 µl of the samples were collected at various time 
points in micro centrifuge tubes. They were then centrifuged at a speed of 3000 rpm and 
resuspended in 1ml of phosphate-buffered saline. In order to capture the cells in their state at 
the time of sampling, Chloramphenicol (34 µg/ml) added to stop all translation and stored on 
ice until the flow cytometry data was obtained. All the flow cytometry experiments were 
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performed on a BD LSR II system (BD Biosciences). FCS Express version 3 (De Novo Software) 
available at the University of Illinois was used for the purpose of data extraction and analysis. 
Table 7. Plasmids used in this study. 
Plasmid Relevant characteristic Reference 
pTJ003 bla Plpp-taz ori p15A (Jin and M Inouye 1993) 
pPROTet.E cm PLtetO-1 ori ColE1 Clontech 
pPROBE-GFP kan GFP[tagless] ori p15A (W G Miller, Leveau, and Lindow 
2000)    
pZE12-luc bla PLlacO-1-luc ori ColE1 (Lutz and Bujard 1997) 
pZE21 kan PLtetO-1 ori ColE1 (Lutz and Bujard 1997) 
pZS24 kan Plac/ara-1 ori pSC101 (Lutz and Bujard 1997) 
pluxRI cm Plac/ara-1-luxR-luxI ori ColE1 (You et al. 2004) 
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Table 8. Plasmids constructed in this study. 
pPROTetE-kan-p15A kan  PLtetO-1 ori p15A  
pGN3 kan PLtetO-1-luxR*  ori p15A 
pGN11 kan PLtetO-1-luxRΔ2-156 ori p15A 
pGN12 kan PLtetO-1-luxRΔ2-162 ori p15A 
pGN23 cm Plux  ori ColE1 
pGN29 cm Plux  -luxR* -GFP [tagless] ori ColE1 
pGN62-Kan kan POmpC-luxRD2-162 ori p15A 
pGN68 cm Plux -GFP [tagless]-luxRΔ2-162 ori ColE1 
pGN69 cm Plux-GFP[tagless] ori ColE1 
pPROTetE-amp bla PLtetO-1 ori ColE1 
pGN76 bla PLtetO-1-taz  ori ColE1 
pGN77 bla PLtetO-1-taz ori pSC101 
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Table 9. Primers used in this study 
Primer name Primer Sequence 
KW134F CAG ATA TCG ACG TCA GTC C 
KW134R2 ATA GAA TTC TGC GTT TAT TCG ACT ATA AC 
GN10F 
 GGG GAA TTC ATA CGT ATT TAA ATC AGG AGT GGA AAT GAG TAA 
AGG AGA AGA ACT T  
GN10R GGG GGA TCC TTA TTA TTT GTA TAG TTC ATC CA 
KW78F1 
 AAC TTT ATA AGG AGG AAA AAC ATA TGA AAA ACA TAA ATG CCG 
AC  
KW078R ACT GTC GAC TTA ATT TTT AAA GTA TGG GC 
KW078F2 TAT GAA TTC AAC TAA AGA TTA ACT TTA TAA GGA GGA AAA ACA 
KW079F ATA GGT CTC TGT GCA AAT GAA ACT CAA TAC AAC 
KW079R ATA GGT CTC TGC ACA TTG GTT AAA TGG AAA GTG A 
KW113F 
CTT TAT AAG GAG GAA AAA CAT ATG CCT TCT CTA GTT GAT AAT TAT 
C 
GN09F2 
AAC TAA AGA TTA ACT TTA TAA GGA GGA AAA ACA TAT GCC TTC TCT 
AGT TGA TAA T  
KW171R AAT AGC GGC CGC TTA TTA ATT TTT AAA GTA TGG GC 
GN09F GGG GGA TCC AAC TAA AGA TTA ACT TTA TAA GGA GGA AAA ACA T 
GN03F GGG CTC GAG GTT CCC TTG CAT TTA CAT TTT  
GN05R GGG GAA TTC TAA CTT TCA TGT TAT TAA CCC 
GN06F2 GGG GTC GAC ATG CCT TCT CTA GTT GAT AA 
GN13F 
GGG GAA TTC TTA AAG AGG AGA AAG GTA CCC ATG ATT AAC CGT 
ATC C 
GN12R GGG GTC GAC TTA CCC TTC TTT TGT CGT GCC CT 
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Chapter 3 Results and Discussion 
The gene amplifier was designed and tested in two different contexts coupled with an 
anhydrotetracycline (aTc) sensor and an aspartate sensor(Nistala et al., 2010). The sensory and 
feedback components were individually tested before integration. The construction and 
characterization of the positive feedback based gene amplifier is described below. 
3.1 One Component Tetracycline Sensor 
The positive feedback based gene amplifier was first constructed and coupled to an aTc sensor. 
Based on the objectives for this study, it was characterized for different properties including 
amplification, hypersensitivity, bistability and memory. All the experiments and the associated 
results are described in different subsections below. 
3.1.1 Effect of the Inducer aTc on Cell Growth 
Anhydrotetracycline, aTc, is an antibiotic derivative of tetracycline and was obtained from 
Clontech® and used as the inducer for experiments involving the PLtetO-1 promoter. Owing to its 
potential cytotoxic effect, it was important to determine the toxic dosage of aTc to the cells. 
Strain GN100 was tested to check for the cytotoxic effects of aTc. GN100 was grown overnight 
in LB media and then diluted 1:100 into six test tubes containing 2 ml of LB each. They were 
then treated to 0, 100 and 250 ng/ml of aTc in duplicates. 500 ul of each of the cultures was 
transferred to a cuvette and the Optical Density (absorbance at 600 nm) was measured 
manually using Amersham Biosciences Ultrospec 10 Cell Density meter ® every 30 minutes until 
the cultures reaches stationary phase (around 12 hours). The results of this experiment are 
shown in Figure 8. The growth of 100ng/ml aTc cultures was not significantly different from 
cultures lacking aTc. However, 250 ng/ml of aTc was detrimental to the growth of the cells. 
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Figure 8. Effect of aTc on cell growth. 
ATc has detrimental effect on the growth of cells. Strain GN100 was treated with 100 (Red 
circles) and 250 ng/ml aTc (Green squares) and grown until stationary phase. Optical Density 
(Absorbance at 600 nm) was recorded every 30 minutes.  Cultures were grown in duplicates. 
Cultures that had no aTc (Blue diamonds) were also grown as control. It was observed that 100 
ng/ml aTc did not show any significant effects on the growth as compared to the control lacking 
aTc. However, 250 ng/ml aTc showed significant detrimental effects on the growth of the cells. 
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3.1.2 Design of the Feedback Component 
In order to construct a stand-alone positive feedback circuit, it is necessary to use an auto-
inducer that does not interfere with native gene regulation in E.coli. Also, it was imperative that 
the activator is constitutively active and is independent of any exogenous inducer to achieve 
cell density independence in order to achieve. Given these constraints, the LuxR protein from 
Vibrio fischeri (Fuqua and Greenberg, 2002) was chosen.  
As described in the Chapter 1, wild type V.fischeri displays N- (3-oxohexanoyl)-homoserine 
lactone (AHL)- mediated quorum sensing and cell density dependent gene regulation for the 
activation of its luminescence (lux) operon by LuxR. LuxR requires sufficient concentrations of 
the diffusible signal AHL, which is a product of LuxI to activate the regulatory region of the 
luxICDABE genes. 
The LuxR protein is 250 amino acids in length and is composed of two functional domains. The 
N-terminal domain is involved in AHL-binding and the C-terminal is the DNA binding 
transcription regulation domain(Slock et al., 1990). The LuxR is a dimer in solution and the DNA 
binding domain recognizes the “lux box”, a symmetric sequence in the promoter region. The lux 
box “ACCTGTAGGATCGTACAGGT” is a 20-bp inverted repeat centered at -42.5 bp from the start 
of luxI transcription. AHL binds to the LuxR monomer, causing a conformational change that 
results in dimerization of the LuxR molecule. The LuxR dimer possesses transcriptional activity. 
Thus wild-type LuxR is dependent on an exogenous inducer. However, a number of structure 
activity relationship studies suggest that specific mutations can cause LuxR protein to become 
AHL independent and thus provide an autoregulatory module that is independent of cell 
density. These specific mutations are described below. 
3.1.2.1 Point Mutations 
Point mutations have been identified that result in the activation of LuxR in the absence of the 
autoinducer(Poellinger et al., 1995). This amino acid residue 221 enables the N-terminal 
domain to inhibit the activity of the C-terminal domain. The Ala221Val (Alanine to Valine) 
substitution renders LuxR capable of activating the expression of target genes independent of 
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the presence of AHL. 
3.1.2.2 Deletion of N terminal Domain 
Deletion of the LuxR N-terminal domain results in a derivative that is able to interact with DNA 
and able to activate the transcription of target genes, in the absence of AHL. Therefore, it was 
concluded that in the native LuxR protein, in the absence of AHL, the N-terminal portion 
reduces the DNA binding affinity of the C-terminal domain (Stevens et al., 1994).  
3.1.2.3 Autoinducer Independence and Activity of the LuxR Feedback Components 
Three constitutively active variants that are known to be autoinducer independent of LuxR 
were engineered to test their suitability in their use as the feedback element of the amplifier.  
1) luxR* : It contains the Ala221Val point mutation.  
2) LuxRΔ2-156: N-terminal deletion from amino acid 2-156 
3) LuxRΔ2-162: N-terminal deletion from amino acid 2-162 
The transcriptional activating strength of these luxR variants on the P luxI promoter was tested in 
comparison to the wild type luxR in the absence of the autoinducer AHL. In order to compare 
the relative strengths of activation, a copy of green fluorescent protein (GFP) was placed under 
the PluxI promoter in plasmid pGN69. The different LuxR variants LuxR*, LuxRΔ2-156, LuxRΔ2-162 
were cloned under the PLTetO-1 promoter and are described as pGN3, pGN11, pGN12 respectively 
in the “Materials and Methods” chapter. They were all transformed individually with plasmid 
pGN69 into strain GN101, which harbors a chromosomal copy of tetR and then induced with 
anhydro Tetracycline (aTc) at 200 ng/ml to induce expression under the PluxI promoter. The 
results are shown in Figure 9. All of the LuxR variants, including the wild-type control, were able 
to induce expression from the PluxI promoter. It was observed that, only LuxRΔ2-162 was capable 
in of enhancing transcription relative to the wild-type control. There was no statistically 
significant difference between the LuxR*, LuxRΔ2-156 and the LuxRwt. Based on these results, 
LuxRΔ2-162 variant was chosen for use in the design of the amplifier.   
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Figure 9. Comparison of constitutive luxR variants. 
a. LuxR was expressed from a tetracycline-inducible promoter, PLtetO-1, in strain GN101, which 
harbors a chromosomal copy of tetR. b. Activity was determined by the ability of these different 
variants to induce expression from the PluxI promoter, using GFP as the readout, in the absence 
of any autoinducer. Dark bars denote the uninduced case and light bars the induced case (200 
ng/mL aTc). Error bars denote 95% confidence intervals. 
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3.1.3 The Sensor Component 
The sensor component was designed to be modular such that any inducible promoter could act 
as the sensor component without requiring changes to the amplifier and reporter system. The 
aTc inducible PLTetO-1 promoter was chosen as the sensor component due to its popularity in the 
literature and availability. In order to test the response of the promoter to the inducer, green 
fluorescent protein  (GFP) was cloned under the PLTetO-1 promoter. The plasmid was then 
transformed into strain GN101 and then induced with various levels of aTc ranging from 0-100 
ng/ml .The cultures were done in triplicates and the GFP expression levels were reported with 
the 95% confidence interval in Figure 10.  
The results demonstrated that expression under the PLTetO-1 could be regulated with various 
levels of aTc induction. This is an important result because it validates the design requirement 
that the strength of the expression of the luxR variants under the control of the PLTetO-1 
promoter should be regulatable.  
The aTc signal recognition by the PLTetO-1 promoter should be transferred to the amplifier. 
Therefore, a copy of LuxR transcriptional activator was cloned under the PLTetO-1 promoter. The 
testing and construction of the pGN3, pGN12 and pGN12 therefore serve the following two 
purposes. 
1) To grade the transcriptional activity of the various LuxR variants. 
2) To provide an initial recognition signal to stimulate the positive feedback circuit.
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Figure 10. Activity of the sensor component. 
a. GFP was expressed from a tetracycline-inducible promoter, PLtetO-1, in strain GN101, which 
harbors a chromosomal copy of tetR. b. Activity was determined by inducing the PLtetO-1 
promoter with various levels of aTc ranging from 0-100 ng/ml and measuring GFP. Error bars 
denote 95% confidence intervals. 
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3.1.4 The Amplifier 
In order to construct the amplifier, GFP and LuxRΔ2-162 were cloned in a bicistronic configuration 
behind the PluxI promoter on high-copy number plasmid (ColE1 origin of replication). In this 
arrangement, LuxRΔ2-162 functions in a positive feedback loop as it can bind to the PluxI promoter 
and activate its own transcription (Figure 11).  
As a control, a non-positive feedback plasmid was also built that lacks the LuxRΔ2-162 .It has GFP 
downstream of the PluxI promoter. The construction of the positive and non-positive feedback 
plasmids pGN68 and pGN69 respectively, is described in Chapter 2. In the positive feedback 
plasmid pGN68 the LuxRΔ2-162 was cloned downstream of the GFP reporter to control for polar 
effects when results involving positive feedback were compared to those lacking it. It ensures 
that GFP is at the same distance from the promoter in the positive and non-positive feedback 
plasmids and in between the same restriction enzyme sites. 
In order to induce the PluxI promoter this circuit, an active variant of LuxR is needed. The most 
active LuxR variant, LuxRΔ2-162, was used this time as the input signal through the use of pGN12. 
The aTc sensor produces LuxRΔ2-162, which in turn activates the positive feedback plasmid 
pGN68.   In this design, the output of the sensor is LuxRΔ2-162, which in turn feeds back into the 
amplifier. In other words, LuxRΔ2-162 is used both as the input and positive feedback signal. For 
the output, we used GFP as it provides a facile measure of transcriptional activity. This choice is 
in no way limiting, and any gene can in practice be used as the output. 
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Figure 11. Schematic of positive-feedback amplifier. 
The basic design for the amplifier consists of GFP and LuxRΔ2-162 arranged in a bicistronic 
configuration under the control of the PluxI promoter. LuxRΔ2-16 functions in a positive feedback 
loop as it can bind to the PluxI promoter and activate its own transcription. In our design, LuxRΔ2-
162 is also used as the input signal to for the amplifier. LuxRΔ2-162, therefore, is used both as the 
input and positive feedback signal. GFP provides a measure of transcriptional activity. 
3.1.5 Validation of Amplifier Using a Tetracycline Sensor 
For the tetracycline sensor, LuxRΔ2-162 was cloned behind the TetR-regulated PLtetO-1 promoter on 
a compatible, medium copy-number plasmid (p15A origin of replication) and described as 
pGN12. In the absence of the tetracycline analogue, anhydrotetracycline (aTc), dimeric TetR 
binds to the O2 operator sites within the PLtetO-1 promoter and represses transcription. 
However, when TetR is bound with aTc, it no longer binds and represses the PLtetO-1 promoter, 
enabling dose-dependent control of gene expression(Lutz and Bujard, 1997). Thus, the aTc-
inducible promoter functions as a one-component tetracycline sensor with LuxRΔ2-162 as the 
output. The amplifier was coupled to the one-component tetracycline sensor (Figure 12) and 
tested.  The sensor and the amplifier plasmids were then transformed into cells (GN100) 
constitutively expressing a chromosomal copy of the tetR gene.  
When this design was tested (Figure 13), it was found that the amplifier (pGN12+pGN68) 
increased both the sensitivity and dynamic range of the integrated circuit relative to an 
otherwise identical circuit lacking positive feedback (pGN12+pGN69) (Figure 12).  
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Sensitivity, in this context, can be described as the ability of the circuit to respond to external 
stimuli aTc in this case. It was found that positive feedback increased the sensitivity to aTc by 
roughly two orders of magnitude. In other words, equivalent levels of expression were 
observed in the circuit involving positive feedback at aTc concentrations roughly one hundred 
times less than those observed with the circuit lacking positive feedback.  
Dynamic range is the ratio of expression under saturating inducing (100 ng/ml aTc) and non-
inducing (0 ng/ml aTc) conditions. The positive feedback increased the dynamic range by 
roughly 50%. 
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Figure 12. Schematic of tetracycline sensor coupled to the positive-feedback amplifier and the 
non-positive feedback control. 
 
a. The one-component tetracycline sensor consists of a plasmid where LuxRΔ2-162 has been 
cloned behind the TetR-regulated PLtetO-1 promoter. In the absence of the inducer 
anhydrotetracycline (aTc), TetR binds to operator sites in the PLtetO-1 promoter and represses 
transcription. In the presence of aTc, TetR cannot bind to the to the promoter, and enables 
dose-dependent control of LuxRΔ2-162. This sensor was coupled with the positive feedback 
amplifier, encoded on a separate plasmid, by transforming cells (GN100) constitutively 
expressing a chromosomal copy of the tetR gene with the two plasmids respectively harboring 
the sensor and amplifier. b. The non-positive feedback plasmid lacks the LuxRΔ2-162 feedback 
element.  
 
48 
 
Figure 13. Comparison of tetracycline sensor with positive feedback (solid circles) and 
without (solid square). 
 
Schematic of positive feedback design is shown in Figure 12. The design lacking positive 
feedback is otherwise identical to one with positive feedback except that only GFP is expressed 
from the PluxI promoter. In these experiments, cells were grown overnight at the indicated 
concentration of aTc to an OD600 prior to measurements. The fluorescence values were 
normalized with the OD600 absorbance to account for cell density. Error bars denote 95% 
confidence intervals for the measurement average. 
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3.1.6 Bistability 
Studies have shown that positive feedback leads to bistable behavior. Cells exhibiting bistable 
behavior tend to remain stably in one of two expression states. Gradient input leads to binary 
output (Ajo-Franklin et al., 2007). At the population level, bistability often leads to bimodality. 
Studies have also shown that noise can induce bimodality without the necessary presence of 
bistability in positive feedback loops (To and Maheshri, 2010). In bimodality the population is 
split into two groups where one group shows basal expression also termed as OFF state and the 
other group exhibits high or maximal expression also called as ON state. The end point 
measurement of expression does not show population level behavior. In order to probe the 
population level behavior of the circuit, the cells were analyzed using fluorescence activated 
cell sorting (FACS). The positive and non-positive integrated circuits were treated with various 
aTc levels ranging from 0 to 100 ng/ml and then FACS analyzed (Figure 14).  
The population of cells carrying the integrated positive feedback circuit displayed basal 
expression and were OFF at 0 and 1 ng/ml aTc induction. When induced with higher levels of 
aTc at 10, 25 and 100 ng/ml all the population turned ON and displayed maximal expression. In 
other words, the population displayed ALL OFF or ALL ON behavior with respect to the inducer, 
with a threshold induction level of 10 ng/ml. It was also observed that there was a very small 
population of ON cells at intermediate induction levels of 10,25 and 100 ng/ml. The presence of 
a third set of population at an intermediate level of expression shows that the population does 
not exhibit bimodality. The population of cells lacking positive feedback displayed a basal 
expression level at 0 and 1 ng/ml aTc induction and displayed gradually increasing expression 
with aTc induction levels of 10,25 and 100 ng/ml aTc. In summary, the circuit with positive 
feedback displayed a bistable behavior but lacked bimodality at the population level. 
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Figure 14. Bistability of the cell population due to positive feedback. 
Cells carrying the positive feedback integrated circuit display ALL OFF or ALL ON (at maximal 
expression) behavior in response to gradient levels of aTc induction as compared to cells lacking 
positive feedback. Cells lacking positive feedback display gradient expression in response to 
increasing levels of aTc induction. 
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3.1.7 Kinetics 
Kinetic experiments were also performed to observe the response over a twelve-hour interval 
to varying concentrations of aTc (Figure 15). Consistent with the end-point measurements, it 
was found that the design involving positive feedback was more sensitive to aTc and had a 
wider dynamic range of expression levels.  
Particular attention should be paid to the expression at 25 ng/ml (green triangles) between 
both the circuits. The positive feedback circuit shows higher final expression relative to the 
circuit lacking positive feedback, which levels off. In case of applications that need higher final 
expression with the lowest possible level of induction, 25 ng/ml would represent an optimum 
level of induction. 
The threshold induction level between positive and non-positive feedback circuits described in 
Figure 13 is different from the threshold value observed in the kinetics. This difference might 
have arisen from the difference in culture volumes. The expression levels in Figure 13 are end-
point measurements of 2 ml cultures where as the kinetics are based on hourly readings of 200 
µl cultures, leading to differences in threshold values as well as kinetics. Collectively, these 
results demonstrate that the genetic amplifier is capable of both increasing the sensitivity and 
dynamic range of this one-component tetracycline sensor.  
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Figure 15. Kinetic analysis of tetracycline sensor with positive feedback (a) and without (b). 
In these experiments, cells were grown for 12 hours at varying levels of aTc induction with 
measurements taken every hour. The fluorescence values were normalized with the OD600 
absorbance to account for cell density. The scale for both sets of experiments is the same.  
Error bars denote 95% confidence intervals for the measurement average. 
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3.1.8 Memory and hysteresis 
Many studies have shown that positive feedback can lead to hysteresis. Hysteresis is history 
dependent behavior. It is easier to maintain the system in one state than to toggle the system 
between two states. Hysteresis is also called memory-like behavior because the expression of 
cells harboring positive feedback circuits at a particular level of induction depends on the 
previous level of induction. In other words, the expression of cells at the current induction level 
would be different if the current induction level was attained through concentration or dilution 
of the inducer.  
In order to display memory like behavior, the cells harboring the positive feedback circuit 
should remember their previous exposures to aTc. In order to show hysteresis like behavior, the 
system requires a larger dosage of aTc to switch from low to high state than from a high to low 
state. In effect, the system should follow a different path when the induction is decreased to 
the same level that the system had experienced before. The cells with the amplifier circuit were 
tested to verify the presence or absence of memory like behavior.  
The cells containing positive feedback and non-positive feedback plasmids were grown over 
night without induction. The cells were then diluted 1:100 into 2 ml of LB containing the 
appropriate antibiotics and grown for 2 hours without induction. They were then induced with 
various concentrations of aTc ranging from 0-100 ng/ml and grown for 8 hours. They were then 
diluted 1:100 into fresh LB media containing antibiotics and lacking the aTc inducer. Samples 
were stored at 0, 1, 2, 8, 12, 14 and 20 hours and analyzed using flow cytometry as described in 
the Materials and Methods section.  
In Figure 16.a, the purple data represents hour 8 (fourth level on time axis) when all the 
samples were diluted into media lacking aTc. If there was memory like behavior then the 
behavior of the system should be path dependent. The expression levels would be different for 
the same level of induction based on if the previous level of induction was higher or lower than 
the current level of induction. The cells harboring no positive feedback displayed basal levels of 
expression after the dilution as seen in 12, 14 and 20 hours for all aTc levels. The cells harboring 
positive feedback circuit however displayed higher GFP expression even after a 100 times 
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dilution as seen in the 12, 14 and 20 hours data for 10 and 100ng/ml aTc induction. After 1:100 
dilution, the carried over aTc would be 0.1 and 1 ng/ml respectively. This data was then 
compared expression from 1 ng/ml aTc induction after 8 hours. The expression at 14 hours (6 
hours after dilution) is similar to expression at 8 hours (before dilution).  These results have 
been summarized in Figure 16.b. 
These results indicate the positive feedback loop involving LuxRΔ2-162 is able to amplify the 
response to an inducer but is incapable of sustaining the response in the absence of inducer. 
Based on the properties of LuxR, specifically the role of AHL in stabilizing LuxR, the reason the 
circuit does not sustain activation is likely due to the protein dimer being degraded too quickly. 
In other words, it can be hypothesized that LuxRΔ2-162 dimer is being degraded at a rate greater 
than it is being produced by positive feedback alone (No specific experiments have been done 
to make this measurement). More specifically, positive feedback alone is unable to sustain the 
expression of LuxRΔ2-162 in the absence of some exogenous source, in our case the one-
component sensor. That said, the positive feedback is still strong enough to amplify the 
response when an external input signal is present. 
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Figure 16.a. Test for hysteresis and memory. 
Cells containing positive feedback and cells lacking it were induced with various levels of aTc 
and then diluted 1:100 into media lacking it after 8 hours of growth (expression show in 
purple). The cells lacking positive feedback displayed basal levels of expression after dilution for 
all aTc levels .The cells carrying the positive feedback circuit at 10 and 100ng/ml induction 
levels, however, displayed higher GFP expression after dilution with an effective aTc 
concentration of 0.1 and 1 ng/ml aTc respectively. 
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Figure 16.b. Summary of test for hysteresis and memory. 
When the expression of positive feedback cells from an original induction of 1 ng/ml aTc after 8 
hours was compared to the expression of cells diluted from original induction of 100 to 1 ng/ml 
at 14 hours (6 hours after dilution), they were strikingly similar. The cells with positive 
feedback, therefore, do not display hysteresis and also do not remember their previous state of 
higher expression at 100ng/ml. In other words, the positive feedback in the current scenario 
does not endow memory. 
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3.2 Two Component Aspartate Sensor  
One of the design objectives was to test the amplifier in various contexts, in order to 
demonstrate it modularity. The amplifier was coupled to a two-component aspartate sensor 
(Figure 19) and tested for amplification and sensitivity. 
The hybrid Tar-EnvZ (Taz) sensor kinase (Jin and Inouye, 1993) was used as the sensor 
component in place of the one-component aTc sensor. This chimeric, transmembrane sensor 
kinase controls the levels of phosphorylated OmpR (OmpR-P), which in turn activates the 
expression from the PompC promoter. When the Taz sensor kinase is bound with aspartate, it 
increases the levels of OmpR-P, leading to increased expression from the PompC promoter. In 
addition to amino acids, EnvZ chimeras have been constructed to sense other inputs such as 
sugars and light (Dattelbaum et al., 2005; Levskaya et al., 2005). 
3.2.1 Testing the Aspartate Sensor 
Two different genomic regions of varying lengths of the OmpC promoter ranging from 2310762-
2310962 and 2310721-2311221 containing the operator sites were chosen to and tested for 
response to aspartate. The reporter green fluorescent protein was cloned behind these two 
promoter regions and tested with varying concentrations of the aspartate inducer as shown in 
Figure 17. The promoter with genomic region 2310762-2310962 responded better to aspartate 
and resulted in higher expression. Therefore this region was chosen for the cloning of the 
plasmid pGN77.  
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Figure 17. Testing the aspartate sensor. 
a. The reporter green fluorescent protein had been cloned behind different lengths of the 
OmpC promoter. The Taz sensor kinase, when bound with aspartate, increases the levels of 
OmpR-P and activates the expression from the POmpC promoter.  b. The blue circles show the 
GFP expression under POmpC from genomic region 2310762-2310962 and the red triangles show 
the GFP expression under POmpC from genomic region 2310721-2311221. The promoter with 
genomic region 2310762-2310962 demonstrated higher expression and had been used for 
cloning the plasmid pGN77. 
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Figure 18. Polar effects of the fluorescence gene. 
The position of the reporter protein relative to its promoter affects the expression. In these 
experiments, the red squares show the expression of the positive feedback circuit in which, 
LuxRΔ2-162 is in between the PluxI promoter and the reporter green fluorescent protein. The 
green circles show the expression of the integrated circuit lacking the positive feedback in 
which the green fluorescent protein is directly behind the PluxI promoter. The blue diamonds 
show the expression of the control circuit carrying the wild type luxR. It can be seen that having 
reporter directly behind the promoter resulted in a basal “leaky expression” even in the 
absence of induction. Therefore, the design was improved to have the reporter at the same 
distance from the promoter in the positive and non-positive feedback plasmids. 
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Figure 19. Schematic of aspartate sensor coupled to the positive-feedback amplifier. 
The two-component sensor consists of the Taz sensor kinase and the OmpR response regulator. 
Taz controls the level of phosphorylated OmpR (OmpR-P), which in turn activates the 
expression from the PompC promoter. When the Taz sensor kinase is bound with aspartate, it 
increases the levels of OmpR-P, leading to increased expression from the PompC promoter. The 
Taz sensor kinase has been cloned behind the constitutive PLtetO-1 promoter one plasmid (the 
cells used in these experiments do not possess TetR).  On a second plasmid, LuxRΔ2-162 has been 
cloned behind the PompC promoter, resulting in the expression of LuxRΔ2-162 being aspartate 
dependent. The third plasmid harbors the positive feedback amplifier. The sensor was coupled 
to the amplifier by transforming the three plasmids into a ΔenvZ null mutant (GN101). 
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3.2.2 Validation of the Amplifier Using an Aspartate Sensor 
In order to couple the two-component aspartate sensor with the genetic amplifier, LuxRΔ2-162 
was cloned behind PompC promoter on a compatible, medium copy-number plasmid (p15A origin 
of replication). In order to introduce the Taz sensor kinase into E.coli, the taz gene was cloned 
behind the constitutive PLtetO-1 promoter on a compatible, low copy-number plasmid (pSC101 
origin of replication). These experiments were performed in cells lacking a chromosomal copy 
of the tetR gene, so the PLtetO-1 promoter in this background is constitutive.  
A design was tested where the positive feedback plasmid and the non-positive feedback 
plasmid differed in the position of the reporter relative to the promoter (Figure 18). The 
position of the reporter protein relative to its promoter affects the expression. The presence of 
reporter protein directly behind the promoter resulted in a basal “leaky expression” even in the 
absence of aspartate induction. Therefore the design was then been improved to have the 
reporter at the same distance from the promoter in the positive and non-positive feedback 
plasmids. 
The three plasmids including the aspartate sensor (pGN77), the luxR input plasmid (pGN62-Kan) 
and the positive feedback plasmid were transformed a ΔenvZ null mutant (GN101) to achieve 
the integrated circuit (Figure 19). As a control, the circuit lacking positive feedback was 
achieved by transforming the plasmids pGN77, pGN62-Kan and pGN69 into strain GN101. 
Similar to observations with the one-component tetracycline receptor, it was found that the 
amplifier increased both the range and sensitivity when coupled to the two-component 
aspartate sensor as compared to an otherwise identical circuit lacking positive feedback (Figure 
20). However, when compared to the one component tetracycline sensor, only a minor 
increase in sensitivity was observed but the amplification response was retained .In particular, 
the amplifier increased the dynamic range by roughly an order of magnitude whereas the 
sensitivity increased by approximately a factor of two. While these results demonstrate that the 
amplifier is modular as it can readily be applied to different sensor systems, they also 
demonstrate that the performance of the amplifier is context dependent.  
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3.3 Results Summary 
In summary, in the context of a one-component sensor, an increase in the sensitivity was 
primarily observed whereas in the two-component sensor, an increase in the amplification. It 
should be noted that only weak activation, roughly two-fold, was observed in response to 
aspartate in the absence of positive feedback. This level of activation is less than what has been 
previously observed in other studies using Taz, where the degree of activation is greater than 
ten fold(Michalodimitrakis et al., 2005; Yoshida et al., 2007). However, unlike the present work, 
these studies measured the expression directly from the PompC promoter.  In the present work, 
the expression was measured from a downstream promoter, PluxI. Thus, there is an additional 
stage between the sensor and reporter in this design. Likely, expression of LuxRΔ2-162 from the 
PompC promoter is not sufficiently strong to activate the PluxI promoter without further 
amplification. However, addition of amplification by including positive feedback results in 
robust expression. 
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Figure 20. Comparison of sensor output in the presence (solid circles) and absence (solid 
squares) of the positive feedback amplifier. 
 
Schematic of positive feedback design is shown in Figure 19. The design lacking positive 
feedback is otherwise identical to one with positive feedback except that only GFP is expressed 
from the PluxI promoter. In these experiments, cells were grown overnight at the indicated 
concentration of aspartate prior to measurements. The fluorescence values were normalized 
with the OD600 absorbance to account for cell density. Inset figure shows the magnification of 
the response for the design lacking positive feedback. Error bars denote 95% confidence 
intervals for measured averages. 
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Chapter 4 Mathematical Model of the Positive Feedback 
The positive feedback has been extensively modeled using differential equation (Ferrell et al., 
2009; Becskei et al., 2001; Keller, 1995; Maeda and Sano, 2006a) and stochastic simulation 
(Pfeuty and Kaneko, 2009) based approaches. There are a number of models with varying 
degrees of complexity that capture the various dynamic and steady state properties of a 
positive feedback circuit.  
4.1 Rate of Synthesis and Decay of Autoregulatory Transcription 
Factors 
Autoregulatory transcription factors can have multiple steady states in the cells causing the 
genetic circuits encoding them to have multiple steady states. The positive feedback model was 
derived with respect to transcription factor and the active transcription activation sites as 
demonstrated by Keller (Keller, 1995). 
 The rate of synthesis of a transcription factor is proportional to the rate of transcription of the 
gene encoding that factor. The rate of synthesis is the sum of products between the frequency 
of each possible configuration of promoter occupancy and the rate of synthesis resulting from 
that configuration. 
Let us assume that the lux promoter has been known to have 2 active sites to which luxR 
activator binds with affinities KA1 and KA2 .The possible configurations of the promoter 
occupancy have been given below along with their relative frequencies and rate of transcription 
factor synthesis. 
[A] is the cellular level of the activator. 
SXA is the activator dependent rate of synthesis of transcription factor X 
SXB is the activator independent rate of synthesis of transcription factor X also known as basal 
expression. 
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The relative frequency for each case scenario is given below for no occupancy, single occupancy 
and double occupancy of the promoter sites by the transcription factor. 
Relative frequency      Rate of synthesis of TF X 
1        SXB 
KA1[A]        0.5SXA+SXB 
KA2[A]        0.5SXA+SXB 
KA1KA2[A][A]       SXA+SXB 
Rate of syntheis of the transcription factor X is then  
              (1) 
The rate of decay can be assumed to be exponential. Considering the case where the 
transcription factor X can homodimerize with dimerization constant KX2 to form X2 and 
heterodimerize with constant KXY to form XY. The monomeric, homodimeric and heterodimeric 
species will each decay with respective decay constants dX, dX2, dXY. 
The overall decay rate of the transcription factor X will then be 
   
          (2) 
At steady state, the rate of synthesis is equal to the rate of decay. If SX0 is the rate of synthesis 
of transcription factor X which produces [X]0 steady state cellular levels of monomer X in the 
presence of [Y]0 steady state cellular levels of monomer Y, then  
SX0-dX [X]0(1+ δX+δXY)=0                 (3) 
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Solving this equation for dx and inserting it into the decay rate equation gives the rate of decay  
                            (4) 
Let us assume that the transcription factor x only homodimerizes, then the rate of decay will be 
  since        δXY =0              (5) 
At steady state  
Rate of synthesis of TF= Production-Degradation=0            (6) 
            (7) 
At steady state the production rate of the transcription factor must equal the degradation rate. 
Equation 7 can be empirically captured by the Hill input function as done by Becskei and 
colleagues (Becskei et al., 2001). Hill input for an activator is a curve that rises from zero and 
approaches maximal saturated level. 
                  (8) 
x is the expression level of the gene amplified by the positive feedback, luxR transcription factor 
TF in the present case, t is time. Only the existent positive feedback from the transcription 
factor has been considered in this case. The variable s is a lumped parameter that takes into 
consideration various parameters like rate of mRNA production through transcription and 
protein synthesis through translation. The variable d is the dissociation constant between the 
activator luxR and lux box, its cognate promoter. d can be  accounted for in s for the sake of 
simplicity. (8) then becomes 

dx
dt

sxn
dn  x n
 kx
b 
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                  (9) 
The variable n is the co-operativity factor capturing the dimerization of luxR and is equal to 2 in 
the current study and k is the degradation rate of the protein. The various behaviors of the 
positive feedback can be explained through the parameters s and k. The activation is done by 
the self-sustaining positive feedback captured through first term in equation 1. The inactivation 
is assumed to be unregulated; its rate is proportional to the amount of x.  
At steady state,  
              (10) 
              (11) 
When synthesis = degradation 
               
(12) 
 
From 11 and 12 
                (13) 
When the transcription factor is a dimer n=2, therefore 
                 (14) 
Bistability is therefore attained when the conditions described in 14 are met. The gain of the 
system can therefore be manipulated by tuning the value of s or d. The gain also depends on 

dx
dt

sx n
1 x n
 kx

d
dx
(
sx n
dn  x n
) 
d
dx
(kx)

sndnx n1  k(dn  x n )2

s  kdn(n 1)
(
1
n
1)

s  2kd
or
d 
s
2k

sxn
dn  xn
 kx
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the unregulated degradation constant k, which is directly proportional to the amount of the 
output. 
4.2 Model Using Ordinary Differential Equation  
Equation 1 has been modeled using ode15s in MATLAB. Various initial conditions are given to 
simulate the effect of the presence of luxR transcription factor at different levels. The final 
steady state expression was determined at 4 different times. The solutions to a first order 
differential equation model of the positive feedback shows the population to divide between all 
‘ON’ and all ‘OFF’ based on the strength of the trancriptional activator and its degradation rate. 
For example, the steady state expression was determined at a constant degradation rate of 
k=0.2, with different binding strengths of the transcription factor s (s = [0.395, 0.4, 0.5, 2, 10];). 
When s=0.395 all the population is turned OFF. When s=0.4, the population is split into no 
expression “OFF” and some expression “ON”. When s=10 all the population is ON. 
At a constant degradation rate k, the ratio of “OFF” to “ON” population can be manipulated by 
varying the strength of s. The final steady state expression level or in other terms “amplification 
due to positive feedback” can also be manipulated by manipulating s. As long as the 
transcription factor is stable and the degradation rate is not high, it is possible to manipulate 
the system behavior from gradient to switch like behavior and at the same time obtaining 
higher amplification and steady state expression levels. The parameter k was varied while s was 
kept constant and vice versa and then the ratio of ON cells to total number of cells 
(ON/ON+OFF) was calculated in order to understand relation between the synthesis of TF and 
its degradation. Figure 21 shows the synthesis-degradation phase space where the ratio 
(ON/ON+OFF) is plotted with relation to s and k. The ratio (ON/ON+OFF) is high when s is high 
and k is low. 
The model of positive feedback captured by the ordinary differential equation using the Hill 
Input Function shows that the ratio of number of ON cells to OFF cells can be controlled. This 
also informs us that the Hill input function is an efficient way of representing positive feedback.  
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Figure 21. The ratio of ON cells to the whole population (ON/ON+OFF) can be controlled by 
manipulating k and p. 
 
The ratio of ON cells to total number of cells (ON/ON+OFF) was calculated in order to 
understand relation between the synthesis of TF and its degradation. Both s and k can be 
manipulated to change the ratio of ON cells to the OFF cells. The ratio (ON/ON+OFF) is high 
when s is high and k is low. 
The response at the single cell resolution was modeled using a stochastic approach. Noise was 
introduced through a random number generator to the initial conditions using the same Hill 
function.  
4.3 Model Using Stochastic Differential Equation 
A stochastic differential equation method was developed for the positive feedback circuit as 
described by Higham (Higham., 2001). Using a stochastic differential equation approach, the 
system response at a single cell resolution when all the cells start from the same state (same 
initial conditions) and the strength of the positive feedback is changed from strong to feeble 
was observed. To track the heterogeneity in the system the time points in between are 
monitored .The final GFP expression is plotted as a histogram. A Monte Carlo approach was 
used where random variables are simulated with a random number generator and the expected 
values are approximated by the computed averages. The random number generator randn 
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from MATLAB was used.  
When the positive feedback is stronger (p=2) than degradation (k=1) the system can be switch 
like or gradient (Figure 22). If Tmax is the total time, the histograms show the output (GFP) and 
the number of cells at three different values of Tmax, 20, 100 and greater than 600. Therefore, 
the stochastic differential equation model of the positive feedback circuit showed that strong 
transcription factor binding strength resulted in stronger feedback activation and caused the 
system to move from gradient to switch like behavior. 
When the positive feedback strength is feeble (p=1 and k=0.9) the system did not exhibit 
gradient to switch like behavior (Figure 23). If Tmax is the total time, the histograms show the 
output (GFP) and the number of cells at three different values of Tmax, 20, 100 and greater than 
600. The stochastic differential equation model of the positive feedback circuit, therefore 
demonstrated that weak transcription factor binding strength couldn’t cause the system to 
move from gradient to switch like behavior. 
Transcription factor binding affinity can therefore cause the positive feedback system to change 
between switch-like and gradient behaviors. The histograms shown in Figure 22 and Figure 23 
look similar to the experimental data shown in Figure 14. The stochastic differential equation 
model, therefore, sufficiently captures the behavior of the positive feedback where the 
population of cells can be modulated from gradient to switch like behavior by manipulating the 
strength of the positive feedback and the degradation rate.  
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Figure 22. SDE model of the positive feedback circuit with strong feedback activation. 
The histograms show the output (GFP) and the number of cells at three different values of Tmax, 
20, 100 and greater than 600. The stochastic differential equation model of the positive 
feedback circuit demonstrates that strong transcription factor binding strength (p=2 and k=1) 
resulted in stronger feedback activation and caused the system to move from gradient to 
switch like behavior. 
 
 
Figure 23. SDE model of the positive feedback circuit with feeble feedback strength. 
The histograms show the output (GFP) and the number of cells at three different values of Tmax, 
20, 100 and greater than 600. The stochastic differential equation model of the positive 
feedback circuit demonstrates that weak transcription factor binding strength and relatively 
high degradation (p=1 and k=0.9) couldn’t cause the system to move from gradient to switch 
like behavior. 
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Chapter 5 Conclusions  
In this work, a modular genetic amplifier based on a constitutively active variant of LuxR was 
successfully developed. The use of autoinducer independent LuxR for construction of positive 
feedback element is truly unique to this study and has not been employed in any other studies 
before. This approach obviates the cell density dependence of the gene regulatory circuit. 
The positive feedback amplifier was coupled to a one-component tetracycline sensor and a 
two-component aspartate sensor and tested. In accordance with the design objectives, the 
amplifier was able to increase the dynamic range and sensitivity of the integrated circuit. The 
amplifier can most likely be coupled to any cell-based sensor where the output involves the 
transcription of a gene. The design objective of modularity was also achieved through the 
positive feedback component. The feedback component was not manipulated and was 
successfully reused in entirety in two different scenarios. The amplifier has also met the other 
criterion of displaying bistability and hypersensitivity.  
In addition to sensing applications, the amplifier can also be used to create devices of greater 
complexity in function. One intriguing application concerns impedance matching. Impedance 
mismatch occurs when the output range of one sub-circuit does not match the input range of 
another sub-circuit to which it is connected. To effectively link these two sub-circuits, the 
respective output and input ranges should match one another. As positive feedback can 
significantly alter the response of a sub-circuit, it can be used as an ‘impedance matching’ 
device by coupling two different sub-circuits together that have disparate requirements for 
signal levels to operate correctly. 
A primary goal of synthetic biology is to design modular components with defined behavior that 
can be reused in diverse applications. The ideal component should have predicable behavior 
regardless of the context in which it is applied. This is a significant challenge.  
While the hypothesis that amplification would be observed due to positive feedback was right, 
a different response was observed when the amplifier was coupled to the two different 
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sensors. For instance, the tetracycline sensor showed a major increase in sensitivity but only 
moderate increase in the dynamic response. The aspartate sensor, however, showed a major 
increase in the dynamic response but only a moderate increase in sensitivity. The amplifier also 
increased background expression in the case of the aspartate sensor but not in the case of the 
tetracycline sensor. The origins of these differences are unknown, but may arise due to 
variations, for example, in plasmid copy number, promoter strengths, and the metabolic 
burden imposed by each circuit. While further engineering can be used to control for these 
individual factors, their effects are often non-trivial to isolate and quantify. 
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